Volker HuppertChief Development Officer at Glycostem TherapeuticsSpeaker
Agenda Sessions
Industrializing 'Off-the-Shelf' Therapies: Scaling Stem Cell-Derived Cell Therapy Manufacturing
, 14:15View Session
